Related Experiment Video
Updated: Mar 26, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
20.2K
Should Barbiturates be Used in Refractory Status Epilepticus?
1Department of Neurology, Epilepsy-Center Berlin-Brandenburg, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Summary
Status epilepticus (SE) is a common neurologic emergency. Refractory SE management requires prompt anesthetic use, with barbiturates, midazolam, and propofol options, though no single agent is definitively preferred.
Area of Science:
- Neurology
- Emergency Medicine
Background:
- Status epilepticus (SE) is a frequent neurologic emergency.
- A significant portion of patients (one-third) are refractory to initial benzodiazepine and second antiepileptic drug treatment.
- Management strategies for SE diverge based on SE type and associated risks.
Purpose of the Study:
- To review the management of status epilepticus, focusing on refractory cases.
- To discuss the role and choice of anesthetics in treating generalized convulsive SE versus complex partial SE.
- To highlight the importance of established treatment protocols.
Main Methods:
- Review of current clinical practices and literature regarding status epilepticus management.
- Comparison of anesthetic agents used in refractory SE.
- Analysis of risk factors for acute complications and long-term consequences.
Main Results:
- Complex partial SE generally has lower risks, often not requiring anesthetics.
- Generalized convulsive SE is life-threatening, necessitating prompt anesthetic intervention.
- Barbiturates, midazolam, and propofol are primary anesthetic choices, each with pros and cons; current data do not favor one over the others.
Conclusions:
- Anesthetics are crucial for generalized convulsive SE, with barbiturates remaining a viable option for refractory cases.
- No single anesthetic agent is universally superior for refractory SE based on current evidence.
- Implementing a standardized in-house protocol for SE management is highly recommended.
More Related Videos
Related Concept Videos
01:20Sedatives and Hypnotics Drugs: Barbiturates
1.3K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.3K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.6K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.6K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.2K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.2K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.6K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.6K